Liberty Health Sciences To Open Its 12th Florida Dispensary In Gainesville
Liberty continues its rapid growth into 2019
TORONTO, March 15, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that the Company is continuing its expansion in Florida and is on schedule to open its 12th dispensary in Gainesville, FL on March 20, 2019, subject to the receipt of Florida Department of Health approvals. The Gainesville area is also home to two Liberty facilities that house an aggregate of 228,880 square feet of cultivation space.
Located at 12 SW 2nd Street, Gainesville, FL, the new dispensary will be open Monday through Friday, 10 a.m. to 7 p.m., Saturday, 10 a.m. to 5 p.m., and Sunday 12 p.m. to 5 p.m. The 1,934 square-foot Gainesville store will provide experienced staff who continue to guide patients through the purchasing process, provide private consultations and host monthly educational events open to the community to discuss the benefits of medicinal cannabis products.
"We are very excited to open our 12th dispensary in the city of Gainesville, which has served as our home and we are delighted to continue to serve the Gainesville community," said Victor E. Mancebo, interim Chief Executive Officer of Liberty. "We continue to aggressively pick up momentum we had in the tail end of 2018, and in 2019 we have announced the opening of three dispensaries, marking this the fourth to open this year. Our Gainesville location will be designed like all of our other sites to bring a contemporary wellness environment with focus on premium patient service.
"Liberty provides its patients with the most up-to-date educational resources and information on cannabis medication. All of our stores meet our high standards for compliance and offer patients an experience they have grown to trust from Liberty throughout the state of Florida," said Mancebo.
Liberty focuses on the patient journey and strives to leave them with a greater understanding of how the product will ultimately help them and how to use it. Today, Liberty operates eleven dispensaries in the following cities across Florida:
• Dania Beach |
• Merritt Island |
• Miami |
• North Miami |
• Palm Harbor |
• Port St. Lucie |
• St. Petersburg |
• Summerfield |
• Tampa (Hyde Park) |
• Orange Park |
• Winter Haven |
Liberty also continues to offer same-day delivery service across the state of Florida in select areas.
About Liberty Health Sciences Inc.
Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty's measured approach to expansion opportunities is focused on maximizing returns to shareholders, while keeping consumers' well-being at the forefront of what we do. For more information, please visit: www.libertyhealthsciences.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "believe", "plan", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company's production capabilities, expectations concerning the receipt of all necessary approvals from the Florida Department of Health, expectations concerning the opening of new dispensaries and the expansion of its greenhouse space, and the Company's future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Liberty Health Sciences Inc.
Share this article